Trial Profile
Phase I pharmacokinetic trial of sublingual apomorphine in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2012
Price :
$35
*
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- 10 Jan 2012 Status changed from recruiting to completed, according to a Cynapsus Therapeutics media release.
- 25 Nov 2011 Planned End Date changed from 31 Dec 2011 to 31 Jan 2012, according to a Cynapsus Therapeutics media release.
- 25 Nov 2011 Status changed from planning to recruiting, according to a Cynapsus Therapeutics media release.